Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.

MLA

Stebbing, Justin, et al. “Mechanism of Baricitinib Supports Artificial Intelligence-Predicted Testing in COVID-19 Patients.” EMBO Molecular Medicine, vol. 12, no. 8, Aug. 2020, p. e12697. EBSCOhost, https://doi.org/10.15252/emmm.202012697.

APA

Stebbing, J., Krishnan, V., de Bono, S., Ottaviani, S., Casalini, G., Richardson, P. J., Monteil, V., Lauschke, V. M., Mirazimi, A., Youhanna, S., Tan, Y.-J., Baldanti, F., Sarasini, A., Terres, J. A. R., Nickoloff, B. J., Higgs, R. E., Rocha, G., Byers, N. L., Schlichting, D. E., … Corbellino, M. (2020). Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Molecular Medicine, 12(8), e12697. https://doi.org/10.15252/emmm.202012697

Chicago

Stebbing, Justin, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J Richardson, Vanessa Monteil, et al. 2020. “Mechanism of Baricitinib Supports Artificial Intelligence-Predicted Testing in COVID-19 Patients.” EMBO Molecular Medicine 12 (8): e12697. doi:10.15252/emmm.202012697.